Rabiel Irene, Majigo Mtebe, Urio Loveness, Nkinda Lilian, Richard Torokaa Peter, Niccodem Elieshiupendo M, Kasubi Mabula, Kamori Doreen, Manyahi Joel, Joachim Agricola
Department of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Tanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, Tanzania.
Ann Med. 2025 Dec;57(1):2550577. doi: 10.1080/07853890.2025.2550577. Epub 2025 Aug 23.
Lower respiratory tract infections (LTRIs) represent a significant global health burden. The clinical presentation of pulmonary tuberculosis (PTB) and other LRTIs often overlap, making it difficult to differentiate based on clinical features only. This study aims to investigate the role of other bacteria pathogens in LRTIs among presumptive TB patients and antibiotic susceptibility patterns for appropriate patient management.
We conducted a cross-sectional study among patients with symptoms and signs suggestive of PTB at Muhimbili National Hospital and Infectious Diseases Centre in Dar es Salaam, Tanzania. Sputum samples collected for TB diagnosis using the original GeneXpert system were investigated for other causes of LRTIs. The sputum samples were assessed for quality based on the Bartlett criteria before culture. We performed descriptive statistics to summarize the data.
We assessed 470 sputum samples, of which 317(67.4%) were of good quality. Of 317 samples, 21(6.6%) were (MTB) positive by GeneXpert, while 126(39.7%) had 138 significant bacterial isolates other than MTB. 44/99(44.4%) was the prominent Gram-negative bacteria isolated, followed by 22/99(22.2%). High rates of resistance was detected towards ampicillin (98%), penicillin (92%), and amoxicillin-clavulanic acid (65%). A high proportion of isolates, 71/138(51.4%) were multidrug resistant (MDR).
This study revealed a high prevalence of LRTIs caused by non-TB pathogens, particularly MDR strains in presumptive TB. MTB was detected only in high‑quality sputum samples. The high resistance rate to commonly prescribed antibiotics for LRTIs called for further large-scale studies to guide and/or refine treatment guidelines and optimize patient care.
下呼吸道感染(LTRIs)是一项重大的全球健康负担。肺结核(PTB)和其他下呼吸道感染的临床表现常常重叠,这使得仅根据临床特征进行区分变得困难。本研究旨在调查其他细菌病原体在疑似结核病患者的下呼吸道感染中的作用以及抗生素敏感性模式,以便对患者进行适当管理。
我们在坦桑尼亚达累斯萨拉姆的穆希姆比利国家医院和传染病中心对有PTB症状和体征的患者进行了一项横断面研究。使用原始GeneXpert系统收集用于结核病诊断的痰标本,以调查其他导致下呼吸道感染的病因。在培养前,根据巴特利特标准对痰标本的质量进行评估。我们进行描述性统计以汇总数据。
我们评估了470份痰标本,其中317份(67.4%)质量良好。在317份标本中,21份(6.6%)经GeneXpert检测结核分枝杆菌(MTB)呈阳性,而126份(39.7%)除MTB外有138株重要细菌分离株。分离出的主要革兰氏阴性菌为肺炎克雷伯菌44/99(44.4%),其次是铜绿假单胞菌22/99(22.2%)。检测到对氨苄西林(98%)、青霉素(92%)和阿莫西林 - 克拉维酸(65%)的耐药率很高。很大一部分分离株,71/138(51.4%)为多重耐药(MDR)。
本研究揭示了非结核病原体导致的下呼吸道感染患病率很高,尤其是疑似结核病患者中的多重耐药菌株。仅在高质量痰标本中检测到MTB。对下呼吸道感染常用处方抗生素的高耐药率要求进行进一步的大规模研究,以指导和/或完善治疗指南并优化患者护理。